|
1
|
Feldtkeller E, Khan MA, van der Heijde D,
van der Linden S and Braun J: Age at disease onset and diagnosis
delay in HLA-B27 negative vs. positive patients with ankylosing
spondylitis. Rheumatol Int. 23:61–66. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zvyagin IV, Mamedov IZ, Britanova OV,
Staroverov DB, Nasonov EL, Bochkova AG, Chkalina AV, Kotlobay AA,
Korostin DO, Rebrikov DV, et al: Contribution of functional KIR3DL1
to ankylosing spondylitis. Cell Mol Immunol. 7:471–476. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fiorillo MT, Haroon N, Ciccia F and Breban
M: Editorial: Ankylosing spondylitis and related immune-mediated
disorders. Front Immunol. 10:12322019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith JA: Update on ankylosing
spondylitis: Current concepts in pathogenesis. Curr Allergy Asthma
Rep. 15:4892015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye G, Xie Z, Zeng H, Wang P, Li J, Zheng
G, Wang S, Cao Q, Li M, Liu W, et al: Oxidative stress-mediated
mitochondrial dysfunction facilitates mesenchymal stem cell
senescence in ankylosing spondylitis. Cell Death Dis. 11:7752020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pishgahi A, Abolhasan R, Danaii S,
Amanifar B, Soltani-Zangbar MS, Zamani M, Kamrani A, Ghorbani F,
Mehdizadeh A, Kafil HS, et al: Immunological and oxidative stress
biomarkers in Ankylosing Spondylitis patients with or without
metabolic syndrome. Cytokine. 128:1550022020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feijóo M, Túnez I, Ruiz A, Tasset I, Muñoz
E and Collantes E: Oxidative stress biomarkers as indicator of
chronic inflammatory joint diseases stage. Reumatol Clin. 6:91–94.
2010.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maksymowych WP, Chiowchanwisawakit P,
Clare T, Pedersen SJ, Østergaard M and Lambert RG: Inflammatory
lesions of the spine on magnetic resonance imaging predict the
development of new syndesmophytes in ankylosing spondylitis:
Evidence of a relationship between inflammation and new bone
formation. Arthritis Rheum. 60:93–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Solmaz D, Kozaci D, Sari I, Taylan A, Önen
F, Akkoç N and Akar S: Oxidative stress and related factors in
patients with ankylosing spondylitis. Eur J Rheumatol. 3:20–24.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fisher FM and Maratos-Flier E:
Understanding the physiology of FGF21. Annu Rev Physiol.
78:223–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Staiger H, Keuper M, Berti L, Hrabe de
Angelis M and Häring HU: Fibroblast growth factor 21-metabolic role
in mice and men. Endocr Rev. 38:468–488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, He C, Liu Y, Li X, Zhang C, Qin Q
and Pang Q: LncRNA-GAS5 inhibits expression of miR 103 and
ameliorates the articular cartilage in adjuvant-induced arthritis
in obese mice. Dose Response. 18:15593258209427182020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Y, Li S, Liu Y, Tian G, Yuan Q, Bai F,
Wang W, Zhang Z, Ren G, Zhang Y and Li D: Fibroblast growth factor
21 (FGF21) ameliorates collagen-induced arthritis through
modulating oxidative stress and suppressing nuclear factor-kappa B
pathway. Int Immunopharmacol. 25:74–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim EK, Lee SH, Lee SY, Kim JK, Jhun JY,
Na HS, Kim SY, Choi JY, Yang CW, Park SH and Cho ML: Metformin
ameliorates experimental-obesity-associated autoimmune arthritis by
inducing FGF21 expression and brown adipocyte differentiation. Exp
Mol Med. 50:e4322018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghaleb AM and Yang VW: Kruppel-like factor
4 (KLF4): What we currently know. Gene. 611:27–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choi S, Lee K, Jung H, Park N, Kang J, Nam
KH, Kim EK, Ju JH and Kang KY: Kruppel-like factor 4 positively
regulates autoimmune arthritis in mouse models and rheumatoid
arthritis in patients via modulating cell survival and inflammation
factors of fibroblast-like synoviocyte. Front Immunol. 9:13392018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Furukawa N, Koitabashi N, Matsui H, Sunaga
H, Umbarawan Y, Syamsunarno MRAA, Yamaguchi A, Obokata M, Hanaoka
H, Yokoyama T and Kurabayashi M: DPP-4 inhibitor induces FGF21
expression via sirtuin 1 signaling and improves myocardial energy
metabolism. Heart Vessels. 36:136–146. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Q, Li J, Ma J, Yang X, Ni M, Zhang Y,
Li X, Lin Z and Gong F: Fibroblast growth factor 21 alleviates
acute pancreatitis via activation of the Sirt1-autophagy signalling
pathway. J Cell Mol Med. 24:5341–5351. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu Q, Sun Y, Li Y, Shi H, Teng J, Liu H,
Cheng X, Ye J, Su Y, Yin Y, et al: Anti-SIRT1 autoantibody is
elevated in ankylosing spondylitis: A potential disease biomarker.
BMC Immunol. 19:382018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen M, Chen C, Gao Y, Li D, Huang D, Chen
Z, Zhao X, Huang Q, Wu D, Lai T, et al: Bergenin-activated SIRT1
inhibits TNF-α-induced proinflammatory response by blocking the
NF-κB signaling pathway. Pulm Pharmacol Ther. 62:1019212020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv C, He Y, Wei M, Xu G, Chen C, Xu Z and
Ding Z: CTRP3 ameliorates cerulein-induced severe acute
pancreatitis in mice via SIRT1/NF-κB/p53 axis. Biosci Rep.
40:BSR202000922020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Neerinckx B, Kollnberger S, Shaw J and
Lories R: No evidence for a direct role of HLA-B27 in pathological
bone formation in axial SpA. RMD Open. 3:e0004512017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong Y, Yan X, Yang X, Yu C, Deng Y, Song
X and Zhang L: Notoginsenoside R1 suppresses miR-301a via NF-κB
pathway in lipopolysaccharide-treated ATDC5 cells. Exp Mol Pathol.
112:1043552020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JW, Bae CJ, Choi YJ, Kim SI, Kwon YS,
Lee HJ, Kim SS and Chun W: 3,4,5-trihydroxycinnamic acid inhibits
lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation in
vitro and improves survival of mice in LPS-induced endotoxemia
model in vivo. Mol Cell Biochem. 390:143–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Golder V and Schachna L: Ankylosing
spondylitis: An update. Aust Fam Physician. 42:780–784.
2013.PubMed/NCBI
|
|
27
|
Geng L, Lam KSL and Xu A: The therapeutic
potential of FGF21 in metabolic diseases: From bench to clinic. Nat
Rev Endocrinol. 16:654–667. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu D, Ye X, Che R, Wu Q, Qi J, Song L, Guo
X, Zhang S, Wu H, Ren G and Li D: FGF21 exerts comparable
pharmacological efficacy with Adalimumab in ameliorating
collagen-induced rheumatoid arthritis by regulating systematic
inflammatory response. Biomed Pharmacother. 89:751–760. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mo X, Chen J, Wang X, Pan Z, Ke Y, Zhou Z,
Xie J, Lv G and Luo X: Kruppel-like factor 4 regulates the
expression of inducible nitric oxide synthase induced by TNF-α in
human fibroblast-like synoviocyte MH7A cells. Mol Cell Biochem.
438:77–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun Q, Gong L, Qi R, Qing W, Zou M, Ke Q,
Zhang L, Tang X, Nie Q, Yang Y, et al: Oxidative stress-induced
KLF4 activates inflammatory response through IL17RA and its
downstream targets in retinal pigment epithelial cells. Free Radic
Biol Med. 147:271–281. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karbasforooshan H and Karimi G: The role
of SIRT1 in diabetic cardiomyopathy. Biomed Pharmacother.
90:386–392. 2017. View Article : Google Scholar : PubMed/NCBI
|
